School Children with Diabetes: Study Finds Better Control with Higher Self-Responsibility

Keith Syverson by Keith Syverson

Surveys have shown that the vast majority of teachers know of at least one student in their school with a chronic illness.  Several studies have investigated the administration of medication in schools from the perspectives of principals or of school nurses, but few studies exist on how students and parents feel about this issue.  A 2008 study in the Journal of School Nursing went directly to the source, interviewing students with diabetes, asthma, and ADHD in order to determine the "types of problems and mistakes [they] experience with their medicines at school."  The group of researchers included pharmacologists and a professor of nursing.  They reached conclusions that surprised them but correspond to modern recommendations for diabetes care.

The researchers initially assumed that the higher the level of responsibility a student has for his or her medication administration, the greater the child's "risk factor index" and the greater the chance of medication error.  The authors state that this index is a combination of risk factors previously identified in the literature and "the collective clinical experiences of the authors."  These included whether the child: transports his or her own medication to school, stores his or her own medication within reach, and whether the child self-administers his or her own medication.  The researchers found that students with diabetes have the highest degree of self-responsibility and thus, as a group, have the highest risk factor index.  Contrary to the initial assumption that a high degree of self-responsibility put the student at a high risk for medication errors, the researchers found that diabetic students had the lowest prevalence of medication error. In contrast, a higher prevalence of errors was reported among children with ADHD who had the least amount of self care responsibility.

Continue reading

Enhanced Privacy, Improved Health through Research: In Today’s World, Does the HIPAA Privacy Rule Do Enough to Ensure Both?

Tim WelchBy Tim Welch

In February 2009, the Institute of Medicine (IOM) released a report, "Beyond the HIPAA Privacy Rule:  Enhancing Privacy, Improving Health Through Research," which outlines the IOM's evaluation of the effectiveness of the 1996 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule in the context of today's electronically-intertwined world.  The report, by the IOM's Committee on Health Research and the Privacy of Health Information, assessed the impact of the HIPAA Privacy Rule on health research in the United States and made recommendations to encourage health research while preserving and improving the privacy protection of personally identifiable health information.

Every American doctor's office contains endless rows of file cabinets which house the confidential medical records of the office's patients.  Modern technology offers us the time- and space-saving convenience of storing, organizing, accessing, and transmitting these records electronically.  However, such a free flow of information—in a less-tangible and more easily-shared form than classic paper records—raises privacy and security concerns.  Medical records often contain personally identifiable information that could be damaging to a patient's dignity and lead to discrimination in other aspects of a patient's life.

Continue reading

CDC Data Highlights a Need for Regulation of Infertility Docs

Jake MeyerLori Andrews
by Jake Meyer and Lori Andrews

The Suleman octuplets have captured Americans’ hearts, but the actions of the mother and doctor have raised people’s ire.  Blogging here last week, Dr. Bruce Patsner pointed out that self-regulation of the infertility industry is insufficient to protect women and children from harm.

Infertility specialist Richard Paulson told Time that we shouldn’t use “this incredibly rare event” to legislate.  But the practice of transferring too many embryos is far from rare and suggests that the billion dollar infertility industry needs stricter oversight.

Continue reading

Digging for Buried Treasure in the Patent Landscape

Jake Meyer by Jake Meyer

In this economy you might be looking for a way to make some money on the side.  If you’re an expert in a field or just a good researcher, a new company offers a way to earn a buck and rid the world of a few bad patents in the process.  But before you start pulling in some extra coin, you may need to know a little bit about patents.

Patents can mean big money for their owners because a patent grants a monopoly over an invention for 20 years after the filing of the patent application.  No one else is allowed to make or use the invention.  So if the inventor creates a new mousetrap, no one else can market that mousetrap or a similar one.  To get a patent the invention has to be novel—the public can’t have known about it before you invented it.  If the USPTO finds that your invention is described in the prior art—previous patents, publications, and other documents—or that your invention was known about or used by others, then the USPTO won’t grant you a patent.  Sometimes, however, non-novel patents slip by the USPTO, particularly when the prior art is hard to find.  For example, if a computer programmer has been using a particular program for years, but no one has a published an article about it and no one has filed a patent on it, the patent examiner may erroneously assume that the program is a new invention and grant a patent, which can be used to stop people from using the same computer program they previously used.

Continue reading

The Octuplets: A Medical Mistake Needing More Regulation?

Bruce PatsnerGUEST BLOGGER Bruce Patsner, M.D., J.D.

The spotlight and the story line have been shifting continuously since the news of the delivery of octuplets by Nadya Suleman was first announced by Kaiser Permanente Medical Center in California on January 26, 2009.  Staged photo shoots of the smiling faces of dozens of physicians and nursing staff involved in the historic Cesarean delivery of the eight premature infants (only the second known living set of octuplets in the U.S.) were quickly replaced by interviews with family members and efforts to secure multi-million dollar contracts for morning talk show appearances.  However, public amazement quickly turned to consternation and in some cases outrage when it was revealed that the birth mother was divorced, unemployed, disabled, on food stamps and already the mother of six previous children.  Kaiser Permanente is asking California taxpayers to foot the bill for the octuplets' seven-figure hospital bill.

Infertility specialists almost immediately began to question the rationale for implanting all eight embryos, and a noted medical ethicist immediately labeled the conduct of all parties concerned "unethical."  A determined but unsuccessful effort began to keep the identity of the infertility specialist who implanted eight embryos from becoming known in the face of mounting public and medical criticism.  Two weeks after the octuplets' birth, the California Medical Board announced that it would investigate the infertility specialist for potential violations of the standard of care.  Ms. Suleman asserted in an interview with NBC News that "Those [the embryos] are my children, and that's what was available and I used them. So, I took a risk. It's a gamble. It always is."

Continue reading

Oops, That Wasn’t a Cell Phone, It Was His Substitute Pancreas

SarahBlennerBy Sarah Blenner, JD, MPH

As Clifton Hassam, a Florida 16 year old junior in high school, sat in class, his blood sugar began to reach dangerous levels.  His monitor, which is attached to his hip, began beeping to inform him of this.  Hassam reached down to turn off the beeping noise and take care of his blood sugar levels.  However, the substitute teacher, believing that Hassam had a cell phone, the use of which during the school day is forbidden, reached down and grabbed the device, pulling out the tubing from Hassam's waist and disconnecting the insulin pump.  It took several days before Hassam's blood sugar reached normal levels again.

Hassam was diagnosed with diabetes when he was six years old.  Like many other individuals with type-1 diabetes, Hassam manages his diabetes in part by wearing an insulin pump, a device that is designed to notify Hassam when his blood sugar reaches unhealthy levels.  According to Hassam, the pump is “my whole life on my side.” The device is about the size of a pager and has a tube (or catheter) that runs under the skin and into the blood stream.  The pump not only monitors blood glucose levels, but it also releases fast acting insulin directly into the blood stream just as a pancreas in a body with normal pancreas function would release insulin into the blood stream.

Continue reading

Genetics and Race: Will New Technologies Reopen the Old Book of Racial Inequality?

Tim WelchBy Tim Welch

In 1883, Sir Francis Galton—a cousin of Charles Darwin—released his book Inquiries into Human Faculty and Its Development, in which the term "eugenics" is used for the first time.  In his book, Galton advocates the need for a term that "takes cognizance of all influences that tend in however remote a degree to give to the more suitable races or strains of blood a better chance of prevailing speedily over the less suitable than they otherwise would have had."  In the 1930s and 1940s, the Nazi party in Germany used eugenic principles as a basis for systematically exterminating millions of people.  In the United States, racial segregation was permitted and practiced until the 1960s.  In South Africa, legally enforced racial segregation lasted until 1994.

Over the past century, civil rights activists have successfully challenged claims that natural or inherent differences between races can be used to justify unequal treatment of certain ethnic and minority groups.  In many countries, racial equality has improved by a vast degree.  The days of attempting to justify racial hierarchies on scientific grounds seem to be in the past.  However, new applications of genetic technologies could come dangerously close to reopening a chapter of human history that many would rather leave closed.

Continue reading

Nanotechnology Could Make Blood Glucose Monitoring Less of a Pain

Jake Meyer by Jake Meyer

In our lifetime, we may see nanotechnology offer improvements in nearly every facet of modern life.  The field of medicine is no exception and nanotechnology research looks to provide technology breakthroughs that will change the way diseases are treated.  Nanotechnology has the potential to improve the treatment of malignant diseases like cancer.  For example, U.S. Patent No. 6,727,065 describes a quantum dot which attaches itself to a cancerous tumor and upon exposure to infrared radiation releases a substance toxic to the tumor.  Nanotechnology also has the potential to improve the treatment of chronic diseases such as diabetes.  Diabetes affects millions of Americans and recent nanotechnology research may lead to a new way of monitoring blood glucose that doesn't involve sticking yourself with a needle.

Researchers at Purdue University have created a biosensor which precisely detects blood glucose.  The biosensor is composed of a single-wall carbon nanotube attached to a gold-coated "nanocube."  The nanocube acts as a sensor and the carbon nanotube acts as a wire to carry electrical signals to electronic circuitry.  The design has been referred to as a tether ball and is well-suited for sensing applications because the sensing portion of the system extends out from the rest of the system allowing it to contact target molecules more easily.  Attached to the nanocube is an enzyme called glucose oxidase.  When the enzyme is in the presence of glucose and oxygen there is an electrochemical reaction that generates an electrical signal, which then travels along the carbon nanotube.

Continue reading

Octuplets: Medical Miracle or Medical Mistake?

Lori Andrews by Lori Andrews

When octuplets were born at Kaiser Permanente Bellflower Medical Center in California, the doctor overseeing the 46 health care professionals in the delivery room called the event "marvelous" and described the mother as "courageous."  But was the event really marvelous?  Or was it a public health nightmare of fertility treatments gone awry?

Between 1980 and 2003, the number of higher-order multiples (triplets or more) increased four-fold.  The prime culprits responsible for this rise in multiples are fertility drugs and in vitro fertilization (IVF).  While other countries regulate the number of embryos that can be transferred to a woman during an in vitro fertilization treatment, the U.S. does not.  As a consequence, one in three in vitro fertilization births involves multiples. 

Continue reading

Legislation Is Needed to Ensure That Students With Diabetes Are Safe at School

JulieBergerBy Julie Burger

As the eyes of Illinoisans (and the world) turn to the impeachment trial in Springfield, it might be tempting to overlook other necessary legislative activity.  Last year, the Care of Students with Diabetes Act was passed in the House, but died in the Senate.  This important legislation would have helped to ensure the safety of children with diabetes at school and clarified the rights and responsibilities of healthcare workers, schools, parents, and the children themselves.

According to data released by the NIH, there are nearly 186,300 children under the age of 20 in the U.S. with diagnosed diabetes.  Type I diabetes occurs in one in every 400 to 600 children within this age group.  Each year, more than 15,000 youth are diagnosed with type I diabetes.  Rates of type II diabetes are also on the rise in children under the age of 20.

Continue reading